Omnio Healer AB
556861-7863ActiveDeveloping regenerative plasminogen therapy to heal chronic wounds effectively.
Biotechnology Companyomnio.se
Yleiskatsaus
- 0
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Charlotta Gummeson
Senior life science executive
Thomas Würdinger
Professor Neuroscience, biotech entrepreneur
Tor Ny
Founder – Head of RnD
Felipe Velasquez
CEO
+6 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Omnio is a biotechnology company focused on revolutionizing chronic wound care. They are developing a next-generation, regenerative therapy utilizing recombinant plasminogen to treat wounds that resist standard care, such as diabetic foot ulcers. This therapy aims to restart the body's stalled natur...
BIOVIVOTECH AS